资讯

Anaerobic membrane bioreactors are an AD configuration that has never been tested for HTL-aq treatment ... The results from this study provide information for process development and future ...
"The next phase of this work is figuring out how to implement our technology in a full process," he said. "That involves carrying out more detailed materials design and development to make the ...
With a 16% lower total cost per run compared to traditional benchtop bioreactors, Stratyx™ 250 enables 25% faster development timelines, 30% improved scale-up success, and real-time process ...
Stratyx™ 250 is an innovative new bioreactor system from Culture Biosciences that accelerates bioprocess development, reduces costs and provides real-time remote control and monitoring for teams ...
SOUTH SAN FRANCISCO, Calif., April 1, 2025 /PRNewswire/ -- Culture Biosciences, a leader in cloud-based biomanufacturing, announced the launch of Stratyx™ 250, the first mobile, cloud-integrated ...